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Introduction
Several antagonistic analogues of luteinizing hormone-releasing hormone (LHRH) have been shown to suppress endogenous LH secretion and to inhibit ovulation in the rat and primates (see Nekola & Coy, 1984) . The results of a limited number of studies in domestic animals suggest that LHRH antagonists can inhibit LH secretion in rams (Lincoln & Fraser, 1987) , fetal lambs (Matwijiw & Faiman, 1986) , and cyclic mares (E. Palmer, personal communication). However, aside from our brief report (Roberge et al, 1987) Hormone assays. The serum concentrations of oestradiol and progesterone were measured as previously described (Guay et ai, 1988) , in the samples taken at 0, 24, 48 h and every 12 h from 54 to 114 h after cloprostenol injection. For the assay of progesterone, the sensitivity, and intra-and inter-assay coefficients of variation were 62-5 pg/ml, 11-5% and 10-4%, respectively. For the assay of oestradiol, the sensitivity, and intra-and inter-assay coefficients of variation were 2 pg/ml, 10-6% and 6-2%, respectively.
The concentrations of LH were measured in duplicate samples of 200 µ serum, exactly as previously described (Kennedy & Rawlings, 1984) . The sensitivity, and intra-and inter-assay coefficients of variation were 62-5 pg/ml, 9-1% and 10-8%, respectively.
Serum FSH concentrations were measured in duplicate samples of 200 µ serum in a heterologous radio¬ immunoassay using 125I-labelled sheep FSH (NIAMDD-oFSH-I-1), an antiserum raised against ovine FSH (NIAMDD anti-oFSH-1) at a final dilution of 1:80 000, and a standard curve of bovine FSH (USDA-bFSH-Bl) varying from 2-240 ng/ml. The labelling and other assay procedures were exactly as previously reported (Kennedy & Rawlings, 1984) . The cross-reaction of the assay was 3-27% for LH (NIAMDD-bLH-4), and < 1% for TSH (NIH-TSH-B5). growth hormone (NIH-GH-B17) and prolactin (NIH-PR-B3). The concentration of FSH in serum from an ovariectomized cow was measured as 120 ng/ml. The sensitivity, and intra-and inter-assay coefficients of variation were 2 ng/ml, 6-3% and 7-7%, respectively. Statistical analyses. All inter-group comparisons were made using the Mann-Whitney U test (Guilford & Fruchter, 1973) .
Results
The effects of the LHRH antagonist on the preovulatory intervals in Exp. I are summarized in Fig.  1 . The interval from cloprostenol injection to oestrus (the time of first injection of antagonist) was not different among the four treatment groups, indicating that they were functionally equivalent at the time of initiation of treatment.
Following antagonist treatment, all animals, except 2 in the 0-8 mg group, ovulated sponta¬ neously. The overall mean (±s.d.) maximum antral diameter of the spontaneously ovulating fol¬ licles was 15-4 + 2-7 mm, and did not differ among treatment groups. The follicular development in the 2 animals that did not ovulate spontaneously was monitored for 13 days after cloprostenol treatment ( Fig. 2) , at which time they were given 1500 i.u. hCG (A.P.L., Ayerst Laboratories, Fig. 1 The serum concentration of progesterone fell to < 1 ng/ml in all animals within 24 h of clopros¬ tenol treatment and was not different among the treatment groups throughout the sampling period.
As shown in Fig. 4 , the times of occurrence of oestrus, the peak serum concentrations of oestra¬ diol, LH and FSH, and ovulation were all significantly delayed in the group treated with 1-5 mg antagonist, compared with the control group. However, when the period from antagonist treat¬ ment to ovulation was subdivided into the periods from treatment to peak serum oestradiol concentration, peak oestradiol to peak LH, and peak LH to ovulation (Fig. 5) , only the interval from the antagonist treatment to the time of the peak serum concentration of oestradiol was signifi¬ cantly longer for the 1-5 mg group (700 ± 6-9 h) compared to the control group (180 + 13-2 h). The antagonist had no effect on either the interval from peak serum oestradiol to peak serum LH, or the interval from peak serum LH to ovulation. (Lucy & Stevenson, 1986 ; and 5 of 6 animals in the control group of Exp. II). There¬ fore treatment with an LHRH antagonist at the onset of oestrus could be expected to exert an effect on the preovulatory LH surge in the majority of animals, but would have no effect on the final stages of follicular growth, which occur before oestrus (Quirk et al, 1986 ). (Nekola & Coy, 1985) , and LHRH-like proteins have been identified in bovine granulosa cells (Ireland et al, 1988) , Brown & Reeves (1983) found no indication of LHRH receptors on the ovary of cattle. Therefore, it is most likely that the effect of the antagonist in Exp. I was due to an effect on the pituitary, inhibiting the preovulatory LH surge.
The 2 animals in which spontaneous ovulation was completely blocked may be of special interest because, although we did not collect blood samples or monitor behaviour in these animals, the continued growth of the largest follicles resembled that of cystic follicles. Ovarian follicular cysts are a significant problem in cattle (see Eyestone & Ax, 1984; De Silva & Reeves, 1988) , and LHRH antagonists could possibly be used to develop a model for studying this syndrome.
In Exp. II, the LHRH antagonist was administered 1 day before the expected time of the onset of oestrus, in order to determine its effects on basal gonadotrophin secretion, and follicular development and function. In this case, the highest dose (1-5 mg) of the antagonist significantly depressed basal LH secretion, and delayed final follicular growth, oestradiol secretion, oestrus, the preovulatory LH and FSH surges, and ovulation. However, the delay of occurrence of the gonado¬ trophin surges was apparently a secondary effect resulting from the delay in follicular development and oestradiol secretion, presumably due to the suppression of basal LH secretion. The intervals from peak oestradiol concentration to the LH surge, and from the LH surge to ovulation were not different among the groups, indicating that the antagonist had no direct effect on the response of the hypothalamo-pituitary axis to the oestradiol surge or on the response of the ovary to the LH surge.
Two approaches have been used to interrupt the trophic effect of endogenous LHRH secretion on the pituitary and thereby suppress endogenous gonadotrophin secretion in female domestic animals. Active immunization against LHRH has been shown to inhibit gonadotrophin secretion and ovarian function in the gilt (Esbenshade & Britt, 1985) , ewe (McNeiUy et al, 1986) , mare (Garza et al, 1986) , and heifer (Johnson et al, 1988) . Alternatively, gonadotrophin secretion and ovulation have been suppressed in the ewe by down-regulation of pituitary LHRH receptors with chronic daily injection (Dobson, 1985) or continuous infusion (McNeiUy & Fraser, 1987) Hansel & Convey, 1983) , superovulation can be induced with exogenous gonadotrophins (see Moor et al, 1984) , and the timing of the preovulatory LH surge (Fernández-Limia et al, 1977) and ovulation (Cumming et al, 1977) can be advanced with LHRH or its agonists. However, to define the role of gonadotrophins in the control of ovarian function more clearly, their endogenous secretion must be suppressed. We believe that LHRH antagonists can be used to satisfy this requirement and thus could add much to the study of ovarian function in the cow.
In practical application, the ability to delay ovulation may be advantageous in the superovulation of cattle, because such treatment results in a considerable incidence of premature ovulation (Caliesen et al, 1987) of immature oocytes (Hyttel et al, 1988) , with a reduced ability to be fertilized. Caliesen et al. (1987) 
